Archive | Journals,Papers & Reports

Study: Common surgical treatment for melanoma does not improve patients’ overall survival

Patients who receive the standard surgical treatment for melanoma that has spread to one or more key lymph nodes do not live longer, a major new study shows.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

VIDEO: Speaker offers updates on combinations, sequencing of immunotherapies for melanoma

NEW YORK — Michael A. Postow, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, addressed the use of immune checkpoint inhibitors at HemOnc Today Melanoma and Cutaneous Malignancies.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

VIDEO: Managing immune-related adverse events requires multidisciplinary approach

NEW YORK — Kathleen M. Madden, MSN, FNP, AOCNP, APHN, a nurse practitioner at the Laura and Isaac Perlmutter Cancer Center at the NYU Langone Medical Center, discussed best practices in identifying and managing immune-related adverse events at HemOnc Today Melanoma and Cutaneous Malignancies.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

Molecule identified that helps give resident T cells in the skin their anti-cancer punch

The molecule CD103 is key to the long-term residence of T cells in the skin and to their anti-tumor function, report a team of researchers at the Medical University of South Carolina (MUSC) and the Dartmouth-Hitchcock Norris Cotton Cancer Center In the April 14, 2017 Science Immunology.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories